ARCHIVES

Novel Compounds Alone Or Combined With Chemo Tested In Blood Cancers

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Balch, Morton Head SSO; Schantz, Rosen Move To MSK; Old Directs US Branch Of Ludwig Inst.

May 10, 1991

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

FDA Grants Accelerated Approval to Imbruvica

November 29, 2013

Survey Shows That One-Third Of Patients Are Undertreated

April 27, 2012

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

Genetronics Phase II Trials For Head & Neck Completed.

May 4, 2001